Clinical Characteristics of Patients Responding to Once-Daily Basal Insulin Therapy in Korean Subjects with Type 2 Diabetes.

导出 OA

翻译打印收藏纠错

作者： Sun Ok,Song ^[1] ; You-Cheol,Hwang ^[2] ; Kyu-Jeung,Ahn ^[2] ; Bong Soo,Cha ^[3] ; Young Duk,Song ^[1] ; Dae Wook,Lee ^[4] ; Byung-Wan,Lee ^[5]

作者单位： Division of Endocrinology and Metabolism, Department of Internal Medicine, National Health Insurance Service Ilsan Hospital, Goyang, South Korea. ^[1] Division of Endocrinology and Metabolism, Department of Internal Medicine, Kyung Hee University School of Medicine, Kyung Hee University Hospital at Gangdong, Seoul, South Korea. ^[2] Division of Endocrinology and Metabolism, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea. ^[3] Novo Nordisk Pharma Korea Limited, Seoul, South Korea. ^[4] Division of Endocrinology and Metabolism, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea. bwanlee@yuhs.ac. ^[5]

关键词 A1chieve? study Basal insulin responder Detemir Korea

DOI 10.1007/s13300-015-0140-0

PMID 26515457

发布时间 2020-09-30

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交